ADAG — Adagene Income Statement
0.000.00%
Last trade - 00:00- $174.85m
- $106.45m
- $7.67m
Annual income statement for Adagene, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 10.2 | 9.29 | 18.1 | 0.103 | 7.67 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 82.5 | 93.2 | 41.8 | 36.1 | 29.1 |
| Operating Profit | -72.4 | -83.9 | -23.7 | -36 | -21.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -71.5 | -79.5 | -17.3 | -33.4 | -17.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -73.2 | -80 | -18.9 | -33.4 | -17.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -73.2 | -80 | -18.9 | -33.4 | -17.6 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -73.2 | -80 | -18.9 | -33.4 | -17.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.46 | -1.48 | -0.346 | -0.594 | -0.298 |